Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Regional Partnership Program Doctoral Research Award

University of Saskatchewan

$33,000.00

Role of Ankyrin3, an ubiquitin adapter protein, in platelet-derived growth factor receptor degradation

FY 2008-09

Summary
Excessive receptor signaling leads to uncontrolled cell division and cancer development. A variety of receptors are displayed on the surfaces of most cells in the body. Generally, these receptors function to detect changes in the outside environment and signal the cell to respond to these changes accordingly. A familiar example of this is the effect of insulin after a meal, signaling the cell to take up glucose. The net effect of signaling from a variety of receptor types is increased cell growth and division. In many cancers, the cellular mechanisms utilized to turn receptor signaling off are either damaged, or the receptors themselves are mutated such that they cannot be shut off. In either case, disruption in the regulation of receptor signaling leads to uncontrolled cell division and cancer. Our laboratory has discovered a means to accelerate the degradation of activated receptors. When a protein called ankyrin3 is produced in cells both the magnitude of signaling generated by the activation of platelet-derived growth factor receptor (PDGFR), a receptor implicated many human cancers, and the levels of this receptor are drastically reduced. In short, Ankyrin3 dramatically increases PDGFR signaling attenuation and receptor degradation. Our laboratory is exploring the mechanism of this effect with emphasis on identifying key players in this process and determining how this process is regulated. We have evidence that ankyrin3 not only attenuates the PDGFR, but also other receptors implicated in cancer and are thus investigating the role of Ankyrin3 as a prototypic regulator of receptor degradation. Many current drugs inhibiting receptor activation have shown clinical results, but display a narrow receptor target range. Thus, studying the effects of ankyrin3 on the down regulation of receptor signaling may provide new targets for the broad therapeutic intervention of human cancer.
Program
Regional Partnership Program Doctoral Research Award
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
188440
Name
Furber Levi A
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of Ankyrin3, an ubiquitin adapter protein, in platelet-derived growth factor receptor degradation
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$33,000
Cihrequipment2
$0
Programname2
Regional Partnership Program Doctoral Research Award
Keyworddelim
Adenovirus; Ankyrin3; Breast Cancer; Cell Culture; Endocytosis; Endosomal Trafficking; Metabolic Labeling; Phosphoinositol-3 Kinase Signaling; Receptor Tyrosine Kinase Degradation; Ubiquitination
Abstract
Excessive receptor signaling leads to uncontrolled cell division and cancer development. A variety of receptors are displayed on the surfaces of most cells in the body. Generally, these receptors function to detect changes in the outside environment and signal the cell to respond to these changes accordingly. A familiar example of this is the effect of insulin after a meal, signaling the cell to take up glucose. The net effect of signaling from a variety of receptor types is increased cell growth and division. In many cancers, the cellular mechanisms utilized to turn receptor signaling off are either damaged, or the receptors themselves are mutated such that they cannot be shut off. In either case, disruption in the regulation of receptor signaling leads to uncontrolled cell division and cancer. Our laboratory has discovered a means to accelerate the degradation of activated receptors. When a protein called ankyrin3 is produced in cells both the magnitude of signaling generated by the activation of platelet-derived growth factor receptor (PDGFR), a receptor implicated many human cancers, and the levels of this receptor are drastically reduced. In short, Ankyrin3 dramatically increases PDGFR signaling attenuation and receptor degradation. Our laboratory is exploring the mechanism of this effect with emphasis on identifying key players in this process and determining how this process is regulated. We have evidence that ankyrin3 not only attenuates the PDGFR, but also other receptors implicated in cancer and are thus investigating the role of Ankyrin3 as a prototypic regulator of receptor degradation. Many current drugs inhibiting receptor activation have shown clinical results, but display a narrow receptor target range. Thus, studying the effects of ankyrin3 on the down regulation of receptor signaling may provide new targets for the broad therapeutic intervention of human cancer.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Furber, Levi A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $33,000~ $0~
University of Saskatchewan - $33,000 Grant (2008-09) | Canada Spends